T A B L E O F C O N T E N T S

Main results
We included 10 studies with a total of 1004 participants. One study evaluated the effect of exercises in the acute and subacute phase after stroke but found no significant difference in rate of falls (rate ratio 0.92, 95% CI 0.45 to 1.90, 95 participants) . The pooled result of four studies investigating the effect of exercises on preventing falls in the chronic phase also found no significant difference for rate of falls (rate ratio 0.75, 95% CI 0.41 to 1.38, 412 participants) .
For number of fallers, one study examined the effect of exercises in the acute and subacute phase after stroke but found no significant difference between the intervention and control group (risk ratio 1.19, 95% CI 0.83 to 1.71, 95 participants) . The pooled result of six studies examining the effect of exercises in the chronic phase also found no significant difference in number of fallers between the intervention and control groups (risk ratio 1.02, 95% CI 0.83 to 1.24, 616 participants) .
The rate of falls and the number of fallers was significantly reduced in two studies evaluating the effect of medication on preventing falls; one study (85 participants) compared vitamin D versus placebo in institutionalised women after stroke with low vitamin D levels, and the other study (79 participants) evaluated alendronate versus alphacalcidol in hospitalised people after stroke.
One study provided single lens distance glasses to regular wearers of multifocal glasses. In a subgroup of 46 participants post-stroke there was no significant difference in the rate of falls (rate ratio 1.08, 95% CI 0.52 to 2.25) or the number of fallers between both groups (risk ratio 0.74, 95% CI 0.47 to 1.18).
Authors' conclusions
There is currently insufficient evidence that exercises or prescription of single lens glasses to multifocal users prevent falls or decrease the number of people falling after being discharged from rehabilitation following their stroke. Two studies testing vitamin D versus placebo and alendronate versus alphacalcidol found a significant reduction in falls and the number of people falling. However, these findings should be replicated before the results are implemented in clinical practice.
P L A I N L A N G U A G E S U M M A R Y
Interventions for preventing falls in people after stroke
Falls are commonly seen in people who have had a stroke and occur in 7% of people in the first week after their stroke. In the later phase after stroke, 55% to 73% of people experience a fall one year after their stroke. Not all falls are serious enough to require medical attention but even non-serious falls may lead to people developing a fear of falling. They are a factor for predicting future falls, which may restrict the person's activities of daily living and therefore require attention. This review investigated which methods are effective for preventing falls in people after their stroke. After searching the literature, we included 10 studies with a total of 1004 participants. We found studies that investigated exercises, medication, and the provision of single lens distance vision glasses instead of multifocal glasses for preventing falls. Exercises did not appear to reduce the rate of falls or the number of people falling. The majority of studies asked participants to do exercises only. One study offered exercises together with additional components such as educational sessions about falls. Another study offered exercises together with a comprehensive risk assessment and subsequent referrals, such as a review by an optometrist or new shoes, leading to a personalised programme for preventing falls. Neither of these two studies reduced the rate of falls or the number of people falling. One study, which gave vitamin D to women after their stroke who had low vitamin D levels and were admitted to long-term care, showed a reduction in the rate of falls and the number of people falling. In another study, alendronate led to a reduction in the rate of falls and the number of people falling in people hospitalised after their stroke. More studies of this kind should be done to confirm these findings before the results are implemented into clinical practice. There is no evidence at the moment that single lens distance vision glasses instead of multifocal glasses reduce the rate of falls or the number of people falling. In summary, there is little evidence that interventions for preventing falls in people after stroke are beneficial. The main reason is that there were only a limited number of studies focusing on people after stroke or that included a stroke subgroup in the study. More research in this important area for people after stroke is therefore warranted.
B A C K G R O U N D
Description of the condition
Falls are one of the most common medical complications after stroke (Davenport 1996; Langhorne 2000) . A recent study including fall events early after stroke showed an incidence of 7% in the first week after stroke onset (Indredavik 2008) . Incidence figures from studies collecting data between one and six months poststroke vary from 25% (Indredavik 2008) to 37% (Kerse 2008) . Studies evaluating participants between six and 12 months after stroke report incidences from 40% (Belgen 2006) to 50% (Harris 2005) . One year after stroke, the reported incidence ranges from 55% (Ashburn 2008) to 73% (Sackley 2008) . Not all falls are serious enough to require medical attention, but non-serious falls are a known predictor for future falls, and can lead to fear of falling, and may restrict a person's activities of daily living. In summary, serious and non-serious falls are still among the most common complications after stroke and their increasing incidence poses a challenge for rehabilitation. Many stroke-related impairments contribute to deficits of balance and falls, e.g. muscle weakness, sensory loss, reduced attention, and abnormalities of vision and spatial awareness (Weerdesteyn 2008) . A fall is a strong predictor of further falls among people with stroke living in the community. However, all people with residual difficulties following a stroke should be considered at increased risk (Ashburn 2008).
Description of the intervention
Few researchers have examined fall prevention or management post-stroke, but interventions recommended for the general elderly population who have experienced falls have been utilised. Preliminary evidence shows that task-specific exercise programmes targeting balance and gait deficits can be beneficial, can reduce fall frequency and are thought to drive neural plasticity (Shepherd 2001) . Technological advances in assistive devices, such as anklefoot orthosis, walking aids (Kuan 1999) and functional electrical stimulation (Burridge 2007) have also been shown to produce evidence of improved mobility, although the benefits with respect to falls prevention in people who have had a stroke still need to be evaluated in intervention studies (Weerdesteyn 2008) .
Why it is important to do this review
A summary of the evidence is important for informing evidencebased practice, and to identify gaps in research. There are existing reviews on the prevention of falls for older people (Cameron 2012; Gillespie 2012). However, a stroke is a serious condition leading to altered physical, cognitive and psychological impairments specifically related to the problem of falls in this population.
In addition, persistent impairments in the later stages after stroke can contribute to the increasing incidence of falls in people after stroke. It is currently very unclear how much research has been dedicated to examining the effect of interventions specific to falls in connection with stroke. This review therefore focuses specifically on interventions for preventing falls in people after stroke.
O B J E C T I V E S
To evaluate the effectiveness of interventions aimed at preventing falls in people after stroke. Our primary objective was to determine the effect of interventions on the rate of falls (number of falls divided by length of follow-up) and the number of fallers. Our secondary objectives were to determine the effects of interventions aimed at preventing falls on (1) the number of fall-related fractures, (2) the number of fall-related hospital admissions, (3) near-fall events, (4) economic evaluation, (5) quality of life, and (6) adverse effects of the interventions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included controlled trials where participants or clusters were randomly allocated. Had any cross-over trials met our inclusion criteria, we would have included the first phase if the order of assignment was determined randomly.
Types of participants
We included trials with adult participants (over 18 years of age) in the acute, subacute or chronic stage following stroke with a confirmed diagnosis. Diagnosis of stroke comprised ischaemic as well as haemorrhagic events. People in the acute stage after stroke were defined as people admitted to a dedicated stroke unit or acute hospital ward. People in the subacute stage after stroke were people admitted to a rehabilitation ward or clinic after being discharged from an acute ward, or people who received intensive treatment at home, for example early supported discharge. Finally, we defined people in the chronic stage after stroke as people who were discharged from rehabilitation and were living at home or admitted to institutional care. We included trials reporting an intervention carried out in a mixed sample of participants, including people after stroke, if data were provided separately (i.e. in a subgroup) for people after stroke.
Types of interventions
We included any intervention where a stated primary or secondary aim was to prevent falls. We classified the interventions according to the taxonomy developed by the Prevention of Falls Network Europe (ProFaNE) (Lamb 2007; Lamb 2011) , which proposes the following categories.
• Exercises (supervised/unsupervised): including gait, balance and functional training; strength/resistance exercises; flexibility exercises (e.g. yoga); 3D training (e.g. Tai Chi, Qi Gong); general physical activity; endurance training or others.
• Medication (drug target): direct action targeted to specific classes of drugs: including antihypertensives, other cardiovascular agents, vitamin D, calcium, other bone health medication, drugs used in diabetes, anti-Parkinson drugs, anti-dementia drugs, antidepressants, antipsychotic/neuroleptic drugs, anxiolytics, hypnotics and sedatives, other central nervous system drugs, urinary antispasmodics or other specified drugs.
• Surgery: including cataract extraction, pacemaker provision, podiatric surgery or intervention, or others.
• Management of urinary incontinence (e.g. assisted toileting, bladder retraining).
• Fluid or nutrition therapy where the basic objective was to restore the volume and composition of the body fluids to normal with respect to water-electrolyte balance (fluid therapy) or to improve the health status of the individual by adjusting the quantities, qualities, and methods of nutrient intake (nutrition therapy).
• Psychological intervention, either individual or in a group, including cognitive (behavioural) intervention, or others.
• Environment/assistive technology, which includes technical aids for people with disabilities.
• Environment (furnishings and adaptations to homes and other premises): direct action including dwelling unit indoors (including entrances), dwelling unit outdoors, public outdoor (e.g. pavement) or relocation.
• Environment (aids for personal mobility such as walking aid, wheelchair).
• Environment (aids for communication, information and signalling): including optical aids, hearing aids, aids for signalling and indicating or alarm systems.
• Environment (body-worn aids for personal care and protection): including body-worn protective aids, clothes and shoes, or others.
• Environmental (social environment): including staff ratio, staff training, service model change, telephone support, caregiver training, homecare services, or others.
• Knowledge interventions: including written material, videos, lectures or others.
• Other interventions/procedures. We classified interventions into single interventions with one component; multiple interventions with more than one component, but the intervention was the same for all participants; and multi-factorial interventions with more than one component and the intervention modified for every participant personally (Lamb 2007) . We compared the intervention for preventing falls with no additional treatment (routine care) or with another type of intervention.
Types of outcome measures
We included only those trials that reported an outcome measure related to the rate of falls or the number of fallers. We included trials where falls were collected either prospectively or retrospectively. We expected to find different definitions of a fall, although a consensus report (Lamb 2005) recommends that a fall should be defined as "an unexpected event in which the participants come to rest on the ground, oor, or lower level."
Primary outcomes
• Rate of falls.
• Number of fallers.
Secondary outcomes
• Number of people sustaining fall-related fractures.
• Number of people with fall-related hospital admissions.
• Number of people with near-fall events (typically defined as an occasion on which a person felt that they were about to fall, but did not actually fall) (Stack 1999).
• Economic evaluation.
• Quality of life (including psychological aspects such as fear of falling).
We developed the MEDLINE search strategy with the help of the Cochrane Stroke Group Trials Search Co-ordinator and adapted it for the other databases. We also searched the following ongoing trials registers (May 2012): ClinicalTrials.gov (http://clinicaltrials.gov/), Current Controlled Trials (www.controlled-trials.com/), International Clinical Trials Registry Platform Search Portal (http://apps.who.int/trialsearch/), and Stroke Trials Registry (www.strokecenter.org/trials/).
Searching other resources
In an effort to identify further published, ongoing and planned trials we:
• checked reference lists of relevant articles;
• contacted trialists and researchers in the field; • used Science Citation Index Cited Reference Search for forward tracking of important articles.
Data collection and analysis
Selection of studies
Two review authors (GV and VW) independently screened the titles, abstracts and descriptors of the records obtained from the electronic searches and excluded obviously irrelevant studies. We obtained the full text of the remaining studies and four authors (GV, VW, SL, and AA) independently assessed these for inclusion based on the review eligibility criteria. We resolved disagreements through discussion and contacted study authors for additional information where required.
Data extraction and management
Three review authors (GV, VW and SL) independently extracted data on to a pre-tested data extraction sheet. We resolved disagreements through discussion, together with the statistical expert (RP).
Assessment of risk of bias in included studies
Three review authors (GV, VW and SL) independently assessed risk of bias for the following items of each included trial (Higgins 2011a): sequence generation (randomisation), allocation concealment, blinding of assessors (for falls) and incomplete outcome data and selective outcome reporting. We included one additional risk of bias item: reliable ascertainment of fall/fallers outcome where 'low risk of bias' means ascertainment of outcome via active registration, e.g. falls diary; 'high risk of bias' if ascertainment relied on participants' recall over a longer period of time (more than one month); and 'unclear risk of bias' if ascertainment relied on participants' recall over a short period of time (one month or less) or if method of ascertainment was not described.
We collected this information on the data extraction sheet and resolved disagreements through discussion.
Measures of treatment effect
We used results reported at one year if these were available for trials that monitored falls for longer than one year, and carried out separate analyses pooling information on rates of falling, and risks of falling once or more within a set time period (preferably a year), following the analyses carried out by Gillespie 2012. We used the generic inverse variance method for pooling rate and risk ratios, which were entered according to the information available in the source papers, and we set the software to display results in the original scale. We obtained standard errors of the logarithm of the intervention effect using the method described in section 7.7.7.3 of the Cochrane Handbook when a properly estimated confidence interval for the intervention effect was presented in the study report. We included properly analysed unadjusted intervention effects if they were available; otherwise, we considered incorporating properly analysed adjusted estimates of effect, or calculated estimates of unadjusted effects depending on the validity of obtaining estimates from the information presented in the source report (see Unit of analysis issues). Where necessary, we calculated rate ratio estimates of treatment effect using the method described in section 9.4.8 of the Cochrane Handbook and calculated risk ratios using the methods described in section 9.2.2. The above analysis was based on that carried out in the Cochrane review of interventions for preventing falls in older people living in the community (Gillespie 2012), and so we anticipated that the same analysis would be appropriate when restricted to studies in people after stroke. For our secondary outcomes (number of people sustaining fallrelated fractures, number of people with fall-related hospital admissions, number of people with near-fall events, economic evaluation, quality of life and adverse events), we expected limited and heterogeneous results throughout the included studies. We therefore provided a narrative description of these results.
Unit of analysis issues
We planned to incorporate any cluster-randomised trials that we found according to the advice in the Cochrane Handbook, section 16.3, and any cross-over trials according to section 16.4.
Dealing with missing data
We contacted study authors to acquire missing data. We planned a sensitivity analysis for studies with missing data (see Sensitivity analysis) but were unable to include this because of the limited number of included studies.
Assessment of heterogeneity
We assessed heterogeneity visually by means of forest plots and by reporting the I² statistic (Higgins 2003) . We carried out analyses of subgroups of studies (in the acute/subacute and chronic phase after stroke) in an attempt to explain heterogeneity by study characteristics. As our search resulted in heterogeneous trials that provided information which could be pooled, we conducted a random-effects meta-analysis incorporating random heterogeneity in intervention effect across studies into the standard error of the effect size, so that our findings can be generalised more widely.
Assessment of reporting biases
We discuss possible problems in the Discussion section of our review. We minimised reporting bias by using a comprehensive search strategy, by searching for studies in other languages than English, and by searching the grey literature (see Searching other resources).
Data synthesis
Since the studies we found were of a heterogeneous nature, we performed random-effects meta-analyses in all cases. We pooled results from comparable single, multiple and multifactorial interventions as defined in the Types of interventions section above and as presented in the Results section below.
Subgroup analysis and investigation of heterogeneity
Based on the results of our review, we presented the effect of interventions for preventing falls in the acute and subacute stages separately from those of people living in the community.
We conducted an investigation of heterogeneity as described in the Assessment of heterogeneity section above.
Sensitivity analysis
Because of the limited number of included studies, we were unable to perform a sensitivity analysis by initially combining low-bias studies, and then adding in the unclear and high-bias studies to check for noticeable changes in the results. For the same reason, we did not conduct a sensitivity analysis to explore the effect of prospective/retrospective data collection or the different forms of data ascertainment described in the Assessment of risk of bias in included studies section. As we found studies that comprised single, multiple and multifactorial interventions, we conducted a sensitivity analysis by omitting multiple and multifactorial interventions from the pooled single interventions.
R E S U L T S
Description of studies
Results of the search
We present the study flow diagram of the results of our searches in Figure 1 . Our search strategies identified 5702 records. Removal of duplicates resulted in 4138 records for initial screening. We obtained a total of 32 full-text papers for further screening. 
Included studies
We included 10 studies with a total of 1004 participants. Details of the included studies can be found in the Characteristics of included studies table, and are summarised below. All studies were individually randomised controlled trials. We did not include any cluster-randomised controlled trials or the first phase of any cross-over trials. The included studies enrolled between 34 (Holmgren 2010) and 170 (Green 2002) participants, with a median sample size of 119 participants. Age (mean: standard deviation (SD)) of the participants for the experimental and control groups ranged from 57 years (11) (for both groups) in Lau 2012 to 78 years (8) and 79 years (8) and this is classified in the ProFaNE taxonomy under Environment/Assistive technology (aids for communication, information and signalling). Holmgren 2010 evaluated the effect of a multiple intervention that largely consisted of individualised and homebased exercises. Finally, Batchelor 2012 examined the effect of a multifactorial intervention that also partly consisted of an individualised home exercise programme but included a comprehensive risk assessment and referral for a wide range of risk factors. For further details of the interventions provided, see Characteristics of included studies. In one study (Green 2002) , the control group did not receive any intervention. In two studies (Batchelor 2012; Haran 2010), the control group did not receive an additional treatment (usual care only). In all other studies, the control group received the same amount of therapy but another type of treatment, although in the case of Holmgren 2010 the treatment for the control group was not dose-matched to that of the intervention group. For further details of the content of the control group, see the Characteristics of included studies table.
Excluded studies
From the 32 full-text papers that we screened, we excluded 13 studies (see the Characteristics of excluded studies table). We excluded most of the studies (nine out of 13) because falls were collected as a measure of an adverse event. These studies, therefore, although reporting falls, did not have the aim of preventing them. We excluded Barreca 2004 because the study was not truly randomised, Eng 2010 because it was a narrative review, Halvarsson 2011 because the subgroup of people with stroke consisted of only four participants, and Mayo 1994 because the author was unable to provide us with details and data for the stroke subgroup. Our searching activities did not identify any ongoing trials. We had insufficient information on four studies, and these await classification. Prior to publication of the review, we identified one additional potential study through contact with an expert: this is also awaiting classification (see the Characteristics of studies awaiting classification table).
Risk of bias in included studies
For five out of six items of our risk of bias assessment, the majority of our included studies scored as having low risk of bias. Only for blinding of outcome assessment (detection bias) did we score the majority of the included studies as having a high risk of bias. Details of risk of bias assessment for each study are shown in the Characteristics of included studies table. Summary results are shown in Figure 2 
Figure 3. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Allocation
We assessed risk of bias for random sequence generation as low in eight studies (80%) and unclear in the remaining two studies (20%). We assessed risk of bias for allocation concealment as low for seven studies (70%) and unclear for the remaining three studies (30%) ( Figure 3 ).
Blinding
With participant recall or active registration of falls by the participant themselves through a falls calendar or diary, we assessed the risk of bias for blinding as high in eight studies (80%) and as unclear in two studies (20%) ( Figure 3 ). In the latter two studies (Sato 2005a; Sato 2011), falls were recorded by nursing staff filling out standardised fall protocols for institutionalised or hospitalised people after stroke, but nurses recording falls would also be dispensing medication.
Incomplete outcome data
We scored the risk of bias for incomplete outcome data addressed as low for eight studies (80%) and high for the remaining two studies (20%) ( Figure 3 ).
Selective reporting
We assessed reporting bias as low in eight studies (80%) and high in the remaining two studies (20%) ( Figure 3 ).
Other potential sources of bias
We also assessed whether the falls/fallers outcome was ascertained reliably. For this item, we scored the risk of bias as low for seven studies (70%), high for two studies (20%) and unclear for the remaining study (10%) ( Figure 3 ). The seven studies that scored low all used a falls calendar that had to be returned monthly with follow-up telephone calls if necessary. The two studies that scored high (Dean 2010; Green 2002) used retrospective recall of six months and three months respectively. We assessed Holmgren 2010 as being at unclear risk because it was not apparent whether the falls calendar that they used for the six-month follow-up had to be returned monthly, three-monthly or after six months, and if there were any follow-up telephone calls.
Effects of interventions Exercises
Our searches identified five studies that evaluated the effect of exercises on falls (Dean 2010; Dean 2012; Green 2002; Lau 2012; Marigold 2005) . As we also identified one multiple trial (Holmgren 2010) and one multifactorial trial (Batchelor 2012) where the intervention largely consisted of an exercise component, we decided to include these two studies under the heading 'Exercises' and combine them with those examining the effect of exercises as a single intervention.
Rate of falls
Data used for this section were based on mean difference reported in Dean 2010, incidence rate ratio reported in Batchelor 2012 and Dean 2012, and incidence rate ratio calculated by the review authors in Lau 2012 and Marigold 2005. No data on falls were obtained from Green 2002 or Holmgren 2010.
Acute/sub-acute stage
The results for falls in Dean 2010 (N = 95) showed that there was a nonsignificant difference in rate of falls between the intervention and the control group (rate ratio 0.92, 95% CI 0.45 to 1.90; Analysis 1.1).
Chronic stage
We pooled the results of four studies (Batchelor 2012; Dean 2012; Lau 2012; Marigold 2005), including 412 participants (Analysis 1.1), giving a nonsignificant difference in the rate of falls (rate ratio 0.75, 95% CI 0.41 to 1.38). We were unable to include other trials that included exercises (Green 2002; Holmgren 2010) in this analysis due to the lack of group-specific information on falls. We did not pool results for rate of falls across both stages because participants in Dean 2010 were hospitalised and in the acute and subacute phase after stroke, whereas the other trials included community-dwelling people in the chronic phase after stroke. When omitting the multifactorial study by Batchelor 2012, our sensitivity analysis of single interventions resulted in a nonsignificant difference in rate of falls (rate ratio 0.65, 95% CI 0.31 to 1.37). We decided against pooling results for number of fallers across both stages after stroke, for the reasons stated above.
Number of fallers
When omitting the multiple study by Holmgren 2010 and multifactorial study by Batchelor 2012, our sensitivity analysis of single interventions resulted in a nonsignificant difference in the number of fallers (risk ratio 1.10, 95% CI 0.86 to 1.41).
Number of people sustaining fall-related fractures
Three studies reported on participants sustaining fall-related fractures. Dean 2012 indicated that one person had a stroke, fractured his shoulder and died in hospital. Lau 2012 reported that none of the falls resulted in any injuries that required medical attention. Finally, one person in the agility group in Marigold 2005 sustained a hip fracture, but on a task that was included in both programmes.
Number of people with fall-related hospital admissions
Only Lau 2012 indicated that none of the falls resulted in any injuries that required medical attention.
Number of people with near-fall events
No study that evaluated the effect of exercises reported on the number of people with near-fall events.
Economic evaluation
No study that investigated the effect of exercises reported an economic evaluation.
Quality of life
Every trial reported on quality of life outcomes. Batchelor 2012 used the Falls Efficacy Scale, Swedish modification, but found no significant result in change scores between groups. Dean 2010 investigated community participation with the Adelaide Activities Profile, but found no significant difference between groups. Dean 2012 used the SF-12 version 2 and the Adelaide Activities Profile. No significant results were found for the SF-12, but improvement in the intervention group was noted for the Adelaide Activities Profile -service to others, and improvement in the control group was reported for the Adelaide Activities Profile -social activities. Green 2002 measured the Frenchay Activities Index, Hospital Anxiety and Depression Scale, and General Health Questionnaire 28, and found no significant differences between groups for any of these measures. Holmgren 2010 used the Falls Efficacy Scale -international version (FES-I) and the Frenchay Activities Index. Improvement in the FES-I (compared with baseline) was significantly greater in the intervention group compared with the control group post-intervention and at three-month follow-up. No significant differences were noted for the Frenchay Activities Index. Holmgren 2010 also reported on the SF-36 and showed significant improvement (compared with baseline), for the intervention group, for the SF-36 mental dimension and mental health subscales at three-month follow-up. Both Lau 2012 and Marigold 2005 used the Activities-specific Balance Confidence (ABC) scale but neither study found a significant between-group difference. Marigold 2005 also measured the Nottingham Health Profile and found no difference in outcome between groups.
Adverse events
Two trials reported specifically on adverse events. Dean 2012 indicated that no falls or other adverse events occurred during the exercise classes, home programme or assessments. Only one participant withdrew because of the intervention, indicating that the exercises had exacerbated an incontinence problem. In Lau 2012, no severe adverse events were reported by the participants, although three indicated mild dizziness during whole-body vibration therapy, and four had lower-limb soreness and fatigue (two from the whole-body vibration group). The authors reported that all symptoms gradually subsided after the first few sessions of training. As mentioned above, one person in the agility group in Marigold 2005 sustained a hip fracture, but on a task that was included in both programmes.
Medication
We present results for this section as originally presented by the study authors.
Rate of falls
Falls were reported both in Sato 2005a and Sato 2011. Sato 2005a indicated that of 158 falls during the two-year follow-up, 22 were in the vitamin D group and 136 in the placebo group. Vitamin D supplementation accounted for a 59% reduction in falls (95% CI 28% to 82%, P = 0.003) after adjustments for the covariates. Sato 2011 reported about 77 falls recorded during the one-year follow-up period, with 10 falls in the alendronate group and 67 in the alphacalcidol group. After adjustments for the covariates, alendronate treatment was associated with a 55% reduction in falls (95% CI 25% to 72%, P = 0.0021).
Number of fallers
Sato 2005a indicated that of 158 falls during the two-year followup period, 11 fallers were in the vitamin D group and 33 in the placebo group. This accounted for a risk ratio of 0.6 (95% CI 0.4 to 0.8) in favour of vitamin D. Sato 2011 reported that during the one-year follow-up, five people fell in the alendronate group and 14 in the alphacalcidol group. This resulted in a relative risk of 0.7 (95% CI 0.5 to 0.9) in favour of alendronate.
Number of people sustaining fall-related fractures
Sato 2005a reported no hip fractures caused by falls in the vitamin D group, but four in the placebo group (log rank, P = 0.049). Sato 2011 indicated that no-one sustained a hip fracture in the alendronate group, compared with one person in the alphacalcidol group.
Number of people with fall-related hospital admissions, Number of people with near-fall events, Economic evaluation, Quality of life, Adverse events
No study that examined the effect of medication reported on these outcomes.
Environment/assistive technology
Results for this section, relating to vision improvement, were based on unpublished data from the stroke subgroup in Haran 2010.
Rate of falls
There was no significant difference in rate of falls when single lens distance vision glasses replaced multifocal glasses for people after stroke (rate ratio 1.08, 95% CI 0.52 to 2.25; Analysis 2.1).
Number of fallers
There was no significant difference in the number of fallers when single lens distance vision glasses replaced multifocal glasses for people after stroke (risk ratio 0.74, 95% CI 0.47 to 1.18; Analysis 2.2).
Number of people sustaining fall-related fractures
No-one with stroke in the intervention group sustained a fracture, compared with one person in the control group .
Number of people with fall-related hospital admissions
One person with stroke in the intervention group was admitted to hospital once, compared with one person with stroke in the control group admitted to hospital three times.
Number of people with near-fall events
There were no reports of near-fall events.
Economic evaluation
The data did not allow us to perform an economic evaluation.
Quality of life
Data from the SF-12 physical and mental component score and Falls Efficacy Scale -International version showed no significant difference between groups.
Adverse events
There were no reports of adverse events.
D I S C U S S I O N
This review focused on the effects of interventions for preventing falls in people after stroke, with secondary outcomes examining the number of people sustaining fall-related fractures, the number of people with fall-related hospital admissions, the number of people with near-fall events, economic evaluation, quality of life (including psychological aspects such as fear of falling), and adverse events.
Summary of main results
Our search strategies resulted in 10 studies being included in this review with a total of 1004 participants. Five studies reported an exercise intervention, two studies the use of medication, one study an environmental adaptation (providing single lens glasses to users of multifocal glasses), one study a multiple intervention, and one study a multifactorial intervention. Since both the multiple and multifactorial intervention largely consisted of an exercise component, both studies were included under 'Exercises'.
Exercises
For rate of falls, results from one study (N = 95) investigating people in the acute and subacute stages after stroke, and pooled results from four studies (N = 412) investigating people in the chronic stage after stroke did not show a significant reduction in the rate of falls. For the number of fallers, results from one study (N = 95) evaluating people in the acute and subacute stages after stroke, and pooled results from six studies (N = 616) evaluating people in the chronic stage after stroke also did not show a significant difference in the number of fallers between both groups. Results for secondary outcome measures were sparse, with the exception of quality of life, but because of the heterogeneity of outcome measures used we decided not to pool these results. Studies assessing the effect of exercises on preventing falls included a total of 12 measures of quality of life. In three of these measures, a significant improvement was reported in favour of the intervention group.
Medication
Vitamin D was shown to reduce the rate of falls and the number of fallers in one study (N = 85) in institutionalised women with low vitamin D levels in the chronic phase after stroke. In another study in hospitalised people in the chronic stage after stroke (N = 79), alendronate was also shown to reduce the rate of falls and the number of fallers. These significant findings should be considered provisional until data from further studies evaluating these interventions confirm the results.
Environmental adaptation (vision improvement)
One study assessed the provision of single lens distance vision glasses instead of multifocal glasses to people after their stroke (N = 46), and did not show a significant reduction in the rate of falls nor a difference in the number of fallers between both groups.
Overall completeness and applicability of evidence
We were only able to include a limited number of trials with a limited number of participants. In comparison, the review evaluating interventions for preventing falls in older people living in the community (Gillespie 2012) included 159 trials with a total of 79,193 participants. Even fewer of the trials presented data required to include them in our analysis of the rate of falls than in the analysis of the number of fallers. Lamb 2005 provided a consensus statement that both outcomes should be provided in trials reporting on interventions evaluating the prevention of falls, and that future trials should include the numbers of both falls and fallers when presenting their results. There is currently insufficient evidence that exercises reduce falling after stroke. Of interest is the result of Marigold 2005, which is the only trial individually demonstrating a significant difference between an intervention programme of agility exercises with a control programme that focused on slow and low-impact stretching and weight-shifting exercises. It should be noted that there is a difference for the analysis and subsequent result between Marigold 2005 and our review. In Marigold 2005, the number of falls and the number of fallers were analysed with a Mann-Whitney U test and a Chi² test respectively, and showed no significant betweengroup difference. Based on the information from Marigold 2005, we were able to calculate the parameters of interest for inclusion into our meta-analysis (see Analysis 1.1 and Analysis 1.2). Surprisingly, for the rate of falls (see Analysis 1.1), this resulted in a significant between-group difference in favour of the agility programme. For planning future trials, this trial seems to give an important message about the content of an intervention to prevent falls. Furthermore, in the smallest study included in this review (Holmgren 2010), significant improvements in favour of the intervention group were noted in measures of quality of life, including the Falls Efficacy Scale -International version and the SF-36 mental dimension and mental health subscales, even at the threemonth follow-up. For intervention content, which was classified as multiple, the intervention group performed the high-intensity functional exercises (HIFE) programme consisting of (1) individualised exercise sessions including physical activity and functional performance, aimed at improving lower-limb strength, balance and gait ability;
(2) implementing the functional exercises into real-life situations; and (3) five one-hour educational sessions with discussions about the increased risk of complications after stroke, such as falls. During the last week of intervention, an individualised home-based exercises programme was designed for each participant. Information from this trial might also be important for planning future trials in this field, but one should remember that differences in the number of fallers were nonsignificant, although it should be noted that the power calculation for Holmgren 2010 was not based on preventing falls but on an improvement of the Berg Balance Scale score. It should be further noted that some trials reported interesting post hoc analyses. Marigold 2005 showed that for their participants with a history of falls, eight out of 15 continued to fall in the intervention group compared with 13 out of 15 in the control group (P = 0.05). Dean 2012 indicated fewer falls in the intervention group for their fast walkers but more falls in the intervention group for their slower walkers. Both studies contribute to the current belief that interventions should be developed for specific subgroups of people with stroke. Again, this information can contribute to the future development of interventions for preventing falls in people after stroke.
As well as the larger number of studies included in the review investigating interventions for preventing falls in the elderly living in the community (Gillespie 2012), there is another contrast with our results: multiple-component group exercises, Tai Chi, and individually prescribed multiple-component home-based exercises did show a beneficial effect for reducing the rate of falls and the risk of falling in this population. We should be cautious, however, considering whether these interventions might be suitable for preventing falls in people after stroke. Two recent trials included in this review (Batchelor 2012; Dean 2012) examined the effect of an intervention containing an exercise programme developed for older people: the Otago Exercise Program (OEP) in Batchelor 2012 and the Weight-bearing Exercise for Better Balance (WEBB) programme in Dean 2012. Neither trial showed significant between-group differences for reducing the rate of falls and the number of fallers, indicating that specific interventions may be required for preventing falls in people after stroke, with strategies aimed at particular deficits that people have after their stroke.
Quality of the evidence
The causes of falls in people after stroke are complex, and a trial aimed at preventing falls requires a complex intervention. We assessed the majority of trials included in this review as having a low risk of selection, attrition and reporting biases, as well as a reliable ascertainment of falls/fallers outcome (see Figure 3 ). Of concern was the level of detection bias (blinding of outcome assessment for falls). In the majority of trials (80%), we assessed this as being at high risk of bias, as studies used a self reported questionnaire or a falls calendar or diary. These methods rely on active registration by the participant, with telephone calls to the participants if (monthly) fall calendars are not returned. Nevertheless, we assessed this as being at high risk of bias, since the assessors, who were in this case the participants themselves, were probably not blinded to group allocation, and because the accuracy of prospective reporting methods may lead to over-or under-reporting of falls (Lamb 2005). Kunkel 2011, comparing retrospective interviews and prospective falls diaries over a 12-month period in a cohort of 122 people with stroke, found an 83% agreement between the methods in the classification of fallers. Yet frequent repeat fallers reported falls during the retrospective interview but did not record all falls in the diary. Excluding these outliers, a similar number of falls were reported using either method. Our results for detection bias and the findings from Kunkel 2011 indicate that monitoring falls accurately in a chronic, community-dwelling population remains difficult. Although prospective methods are considered preferable (Hauer 2006) , future trials could include both retrospective and prospective methods. Nevertheless, preliminary studies investigating novel assessments of falls, such as portable activity monitors, seem warranted for future research. Another concern arising from the trials included in this review is the definition of falls. Of the 10 trials, only seven provided a definition of a fall and, among these five different definitions were used, with two trials (Sato 2005a; Sato 2011) presenting a definition not referenced to previous literature. Although the content of these different definitions might not be significantly different, uniformity should be sought in future trials evaluating interventions for preventing falls in people after stroke, with a consensual definition of a fall, such as the one developed by the Preventions of Falls Network Europe (Lamb 2005).
Finally, for six out of 10 trials, the primary aim was to prevent falls. For five of the six, a power calculation was also performed based on establishing a reduction in falls/fallers. The single aim of Holmgren 2010 was to prevent falls, but the power calculation was based on finding an increase in the Berg Balance Scale score, leading to a total of 34 participants recruited. The nonsignificant finding for falls and fallers may have resulted from an inadequate sample size for this outcome. Unpublished stroke subgroup results from Haran 2010 should also be interpreted with caution; this analysis is underpowered, since a limited group of the total study sample was selected for our analysis. Future trials need to be of adequate size, with a power calculation based on reasonable estimates of effect size, resulting in trials with many more participants. As an example, Marigold 2005 calculated that, based on their fall data, a sample size of 292 participants per exercise group would be required to detect differences for the number of fallers in a future definitive trial. Future trials will probably need to be multicentred and perhaps international.
Potential biases in the review process
Although we developed comprehensive search strategies for our review, there is still a possibility that we have missed some trials. Nevertheless, as an international group, we are familiar with the work of colleagues from around the world active in the domain of falls after stroke, so we were able to include studies reporting on trials that were only recently completed. Another potential bias of our review might be that we excluded trials that reported falls as an adverse event. It could be hypothesised that, although falls were included in these trials despite the fact that the interventions were not aimed at preventing them, some of them might actually have a positive effect on falls or the number of fallers, or both. Furthermore, one could disagree with our inclusion of Lau 2012 and Marigold 2005 in our pooled analysis, as both arms of these trials received an active exercise component. We believe that our decision was justified as, firstly, there is a general mixture of types of control interventions across our studies, and secondly -and more importantly -we believe that the experimental intervention in both these studies was focused on significant aspects of falls prevention. In Lau 2012 the intervention group conducted whole-body vibration exercises; vibration is thought to improve muscle weakness, the latter being an important predictor for falls (Weerdesteyn 2008) . Similarly, in Marigold 2005, the aim of the agility exercises in the experimental group was also clearly more related to falls prevention than the stretching and slow, low-impact weight-shifting exercises conducted in the control group. Finally, although we were able to obtain data from one study where a subgroup of people with stroke was included, we did not use a systematic approach to obtaining falls data for subgroups of participants with a history of stroke in all fall prevention trials. Despite this, there is strong agreement in identified studies between this review and Batchelor 2010, who also reviewed interventions for falls prevention after stroke. It is reassuring that two independent groups reviewing the same topic largely identify the same studies.
Agreements and disagreements with other studies or reviews
Our search strategy identified one systematic review on the topic of falls prevention after stroke. Batchelor 2010 included 13 studies and their results are in agreement with those of this review. They also found that the only intervention shown to be effective in reducing falls was vitamin D for institutionalised women after stroke with low vitamin D levels (Sato 2005a). However, there is a discrepancy between the studies included in Batchelor 2010 and our review. In Batchelor 2010, the type of interventions included were all those that may affect falls outcome. On that basis, they also included trials in which falls were classified as an adverse event.
Their review therefore contains six trials that we have excluded from our review, because we applied the stricter inclusion criterion that interventions had to be aimed at preventing falls. This is an important distinction. Trials evaluating interventions such as very early mobilisation after stroke or early supported discharge include falls as an outcome. However, the aim of these interventions is not to prevent falls but to improve functional outcome. Because (very) early mobilisation or early supported discharge might be associated with an increase in falls, they are included as an outcome measure. We believe that a stricter approach, i.e. including only trials where the aim was to prevent falls, is justified, as otherwise study hypotheses are mixed and results become difficult to interpret.
A U T H O R S ' C O N C L U S I O N S
Implications for practice Exercises
Currently, there is insufficient evidence that exercises, as a single component or integrated into a multiple or multifactorial intervention, significantly reduce falling after stroke. There is also insufficient evidence relating to the prevention of fall-related fractures, fall-related hospital admissions, near-fall events, economic factors, quality of life, or adverse events to inform practice.
Medication
One study showed that vitamin D reduced falling in institutionalised women in the chronic phase after stroke with low vitamin D levels. Another study showed that alendronate also reduced falling in comparison with alphacalcidol in hospitalised people in the chronic stage after stroke. Both studies need to be replicated before implementation of these interventions can be used in clinical practice.
Environmental adaptation (vision improvement)
One study provided people with stroke with single lens distance vision glasses instead of multifocal glasses, but did not find a significant decrease in the rate of falls or the number of fallers.
Implications for research
This review provides little evidence for the effectiveness of interventions for preventing falls in people after stroke. Further research into this important but complex area is warranted.
Further studies are needed to assess exercises as a single component or part of a multiple or multifactorial programme, with careful consideration of the content of the intervention, taking into account the current knowledge about risk factors for falling after stroke and the possibility that different interventions have to be developed for different subgroups of people after stroke.
It is important to note that only one study included participants in the acute and subacute phase. Future research could focus on the potential of influencing risk factors for falls in people early after stroke, i.e. while still hospitalised, and on the assessment of the long-term effect when people are discharged back into their community.
Further trials assessing medication are needed to confirm previous findings before recommendations for clinical practice can be made.
Studies investigating fall prevention for people after stroke should be adequately powered, provide a standardised definition of a fall from a consensus statement, use appropriate and accurate methods of fall ascertainment, and apply the current standards for analysis and reporting of data, including the CONSORT guidelines.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Batchelor 2012
Methods A single blind, multicentre RCT with 12-month follow-up Participants A total of 156 participants were recruited. Participants were people with stroke at risk of recurrent falls being discharged home from rehabilitation
Interventions
In addition to usual care after discharge (physiotherapy and occupational therapy and follow-up by the general medical practitioner), the 12-month study programme consisted of: For the intervention group (N = 71): a physiotherapist providing a multifactorial, individually-tailored falls prevention programme, consisting of: (1) Low risk Quote: "The allocation sequence was computer-generated before commencement of the study and centrally located." (page 98)
Allocation concealment (selection bias) Low risk Quote: "After recruitment, the central office was contacted for allocation so that randomisation was secure and concealed." (page 98) 
Dean 2012
Methods An assessor-blinded RCT Participants A total of 151 community-dwelling people after stroke
Interventions
Both groups participated in exercise classes of 45 to 60 minutes delivered by a physiotherapist weekly for 40 weeks over a 1-year period consisting of: For the intervention group (N = 76): an exercise intervention designed to enhance mobility, prevent falls, and increase physical activity -the WEBB programme involving taskrelated training with progressive balance and strengthening exercises as well as walking and stair climbing. The intervention was delivered in a weekly circuit-style group exercise class and a home exercise programme (to be completed at least 3 times per week), and advice to increase walking was given For the control group (N = 75): the exercise class was designed to improve upper limb function, manage upper limb contracture with task-related strength and co-ordination training, and improve cognition with matching, sorting and sequencing tasks. The control group was also prescribed a home programme (to be completed at least 3 times per week)
Outcomes
Rate of falls, number of fallers, quality of life, and adverse events
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk Quote: "The allocation sequence was computer generated before commencement of the study ..." (page 2)
Allocation concealment (selection bias) Low risk Quote: "... and a set of consecutively numbered, sealed opaque envelopes containing the allocation was centrally generated for each stroke club." (page 2) Heterogeneity: Tau 2 = 0.01; Chi 2 = 5.88, df = 5 (P = 0.32); I 2 =15%
Test for overall effect: Z = 0.15 (P = 0.88) Test for subgroup differences: Chi 2 = 0.60, df = 1 (P = 0.44), I 2 =0.0% S44 PT multicenter study S45 TX multicenter study Search modes S46 PT (evaluation studies or comparative study) S47 TX (evaluation studies or comparative study) S48 TX random* S49 TX controlled AND TX (trial* or stud*) S50 TX clinical* trial* S51 TX (control or treatment or experiment* or intervention) AND TX (group* or subject* or patient*) S52 TX (quasi-random* or quasi random* or pseudo-random* or pseudo random*) S53 TX (multicenter or multicentre or therapeutic) AND TX (trial* or stud*) S54 TX (control or experiment* or conservative) AND TX (treatment or therapy or procedure or manage*) S55 TX coin AND TX (flip or flipped or toss*) S56 TX versus S57 TX (cross-over or cross over or crossover) S58 TX placebo* S59 TX sham S60 TX (assign* or alternate or allocat* or counterbalance* or multiple baseline) S61 TX controls S62 TX treatment* AND TX order S63 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 S64 S28 AND S64 S65 S28 AND S64 Limiters -Population Group: Human
